Australian (ASX) Stock Market Forum

AXE - Archer Materials

At the current SP of $1.63, i would expect a bit of a flurry on the SPP at $1.45 for around $5 mil.
Will be interesting to see if it closes early.

Chart looking interesting also, almost like it wants to break out?, however, I would expect some tethering to the SPP price to keep a lid on things for a while...however US chipmakers up nicely overnight, so who knows?

Screenshot_20211015-085054.png
 
At the current SP of $1.63, i would expect a bit of a flurry on the SPP at $1.45 for around $5 mil.
Will be interesting to see if it closes early.

Chart looking interesting also, almost like it wants to break out?, however, I would expect some tethering to the SPP price to keep a lid on things for a while...however US chipmakers up nicely overnight, so who knows?

It's right on significant resistance at 1.63 and about to hit 20d sma. Would be a feat to get straight through.
 
It's right on significant resistance at 1.63 and about to hit 20d sma. Would be a feat to get straight through.
Yep, a little tethered to that $1.45 price untill SPP closed.

Meanwhile,
AXE weilders eligible to receive the new ITM Itech shares should see there new holdings today.
Mine are in.
 
SPP results announcement today indicating good demand, imo.

"The SPP was originally targeting to raise $5 million.
Due to significant demand from eligible shareholders, on 18 October 2021, the Company announced the amount raised under the SPP would be increased to $10 million.

The Company has received subscriptions for $25.4 million, which means that SPP applications will all be scaled back in accordance with the terms of the SPP offer document dated
7 October 2021.

The new SPP shares are expected to be allotted on 27 October 2021."

Approx 6.9 million shares to be issued.
 
ASX Announcement (ASX: AXE)
4 November 2021

Early-stage assembly of biochip components

Highlights

• Archer fabricates and integrates nanosized biochip components in microfluidic channels on chip compatible substrates.

• The microfluidic channels are less than 20 micrometres in width (about 3 times thinner than a human hair).

• The work validates the Company’s early-stage capabilities in developing a
significant aspect of lab-on-a-chip devices†, required for the future
operation of Archer’s biochip.

• Lab-on-a-chip devices are a subset of Sensors/MEMS products that represent a high-growth opportunity in the semiconductor industry‡.
 
A quick squiz at the chart and the accumulation/ distribution indicator.
A 3 month daily chart shows an upturn in accumulation.
More pronounced on a 1 month chart, see below.
To me, this confirms my bias of "untethering" from recent CR/SPP price of $1.45
I suspect most profit takers have been shaken out by now...?

Screenshot_20211104-111947.png
 
A quick squiz at the chart and the accumulation/ distribution indicator.
A 3 month daily chart shows an upturn in accumulation.
More pronounced on a 1 month chart, see below.
To me, this confirms my bias of "untethering" from recent CR/SPP price of $1.45
I suspect most profit takers have been shaken out by now...?

View attachment 132403
Looks like the uptrend has resumed, at least on this shorter-term time scale.

Was also covered as a news podcast elsewhere...

1636036445545.png
 
Interesting, I wasn't aware of Archers other deep tech research in medical diagnostics "Lab in a chip".
Today's price BO of the ledge looks promising.
Looking at a 3 month or 6 month chart, I'm seeing a rounded double bottom.
Am no expert on double bottoms, but I believe they are known to be bullish.
Am guessing, because it is rounded, it's been created by lower than average volatility?

What I'm really wondering is;
if double bottoms are seen as bullish, is a sharp w pattern more attractive as a signal, or a smooth rounded one?

On a side note, have observed some US stocks overnight, that may or may not have some bearing on AXE today.

Notably;
QUALCOMM up 12.7%
NVIDIA up 12%
AMD up 5.3%
NASDAQ up 0.8%

I note that AXE has recently changed the sector they resided in.
Previously was Materials I believe?
Is now in the Semiconductors & Semiconductors equipment sector.

Screenshot_20211105-075643.png
 
What I'm really wondering is;
if double bottoms are seen as bullish, is a sharp w pattern more attractive as a signal, or a smooth rounded one?
I think they both have some merit.

However round bottoms take a lot of bars to form usually, therefore can have more validity. A W bottom can form just in the thick of volatility with just a few price bars, so need to be taken in perspective.
 
Well, I hope the market is pleased with itself.
Have just found it stopped me out at 3:59pm... had just raised the bar on it last night too. ?
Wil be very hissed if it gaps up on Mundy.
 
Hot off the press.

ASX Announcement (ASX: AXE)
1 December 2021

Archer develops sensing pathways to detect genetic
information

Highlights
• Archer has developed its first biochemical reactions for application in its
biochip technology.

The reactions have the potential for on-chip detection and quantification of specific DNA or RNA fragments relevant to viruses and bacteria.

• The work is a significant step in the Company’s development of its biochip†, providing potential reaction mechanisms for the technology’s future operation and applications in disease detection.

• The biochip has been developed in-house by Archer staff and Archer owns 100% of the biochip technology intellectual property.


Might put a rocket onto it in the current Omicron market sentiment?
 
Quantum computing and Human Health.
What's not to like about this AXE innovation, creating a room temperature qubit processor?
Healthwise, one thing AXE is planning, along with patent and IP creation, is rapid multi-disease detection biochips.
 
Hot off the press.

ASX Announcement (ASX: AXE)
1 December 2021

Archer develops sensing pathways to detect genetic
information

Highlights
• Archer has developed its first biochemical reactions for application in its
biochip technology.

The reactions have the potential for on-chip detection and quantification of specific DNA or RNA fragments relevant to viruses and bacteria.

• The work is a significant step in the Company’s development of its biochip†, providing potential reaction mechanisms for the technology’s future operation and applications in disease detection.

• The biochip has been developed in-house by Archer staff and Archer owns 100% of the biochip technology intellectual property.


Might put a rocket onto it in the current Omicron market sentiment?
Where’s the rocket?
 
What are we thinking here team on the current accumulation phase being ready to launch in an upward trajectory in 2022?
This is one of the top picks for me this year with some strong projects being realised.
 
Top